DR - Medical Facilities Corporation (TSX) - Share Price and News

Medical Facilities Corporation
CA ˙ TSX ˙ CA58457V5036
$14.77 ↑0.19 (1.30%)
2025-09-04
SHARE PRICE
Overview
Medical Facilities Corporation, based in Canada, operates in the healthcare sector, primarily focusing on the ownership and management of specialty surgical hospitals and ambulatory surgery centers in the United States. The company has strategically positioned itself in the market by partnering with experienced physicians who co-own its facilities, thus ensuring high-quality care and operational efficiencies. Key projects include a robust portfolio of non-emergency surgical, imaging, and diagnostic services, offering procedures that range from orthopedic surgery to neurosurgery. This focus not only aligns with current healthcare trends towards outpatient surgical services but also caters to an increasing demand for specialized and high-acuity healthcare services.
Basic Stats

The share price of Medical Facilities Corporation as of September 4, 2025 is $14.77 / share. This is an increase of 1.16% from the prior week. The market cap (or net worth) of Medical Facilities Corporation as of September 5, 2025 is $278.53 MM.

The Factor Analysis chart (below right) shows a view of Medical Facilities Corporation from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.

For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.

Market Cap 278.53 MM
EV
Shares Out. 18.86 MM
Earnings Date
EPS (TTM) 4.27
Dividend Yield 2.44 %
Ex-Dividend Date 2025-09-29
Borrow Rate 5.08
Short Shares Avail. 0.75 MM
Short Interest
Short Float
Days to Cover
Risk Free Rate 4.17 %
Price Change (1 yr) 9.16 %
Volatility (1 yr) 0.27
Beta 0.44
Sharpe Ratio (1 yr) 0.19
Sortino Ratio (1 yr) 0.33
PE Ratio
Price/Book
Price/TBV
Book/Market
EBIT/EV
EBIT(3yr avg)/EV
ROA 0.24
ROE 0.73
ROIC 0.48
CROIC 0.18
OCROIC 0.36
Implied Volatility
Put/Call OI Ratio
Growth 46.14 /100
Profitability 96.35 /100
Quality Score 77.12 /100
Value Score
Momentum Score 35.04 /100
Stability (Low Vol) Score 78.47 /100
Analyst Sentiment 22.11 /100
Fund Sentiment 42.86 /100
Insider Sentiment
Officer Sentiment
Dividend Score 52.97 /100
QVM Score
Piotroski F-SCORE 7.00 /9
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target

The average one-year price target for Medical Facilities Corporation is $16.58. The forecasts range from a low of $15.66 to a high of $17.85. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.

Update Frequency: Monthly

Record Date Projection Date High Low Median Average
2025-09-02 2026-09-02 17.85 15.66 16.58 16.58
Stock Upgrades/Downgrades

This card shows analyst upgrades/downgrades for Medical Facilities Corporation. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.

The standard analyst ratings are generally as follows:
  • Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
  • Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
  • Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.

When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.

The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.

Date Analyst Prior Latest
Recommendation
Action
2022-11-12 Leede Jones Gab Hold Downgrade
2022-11-11 RBC Royalbank Sector Perform Downgrade
2022-11-11 National Bank of Canada Financial Downgrade
2022-09-15 National Bank of Canada Financial Sector Perform Initiate
2022-05-16 RBC Royalbank Sector Perform Downgrade
2022-05-13 National Bank of Canada Financial Sector Perform Downgrade
2022-03-11 RBC Royalbank Sector Perform Upgrade
2022-03-11 National Bank of Canada Financial Outperform Upgrade
2021-11-12 RBCRoyalBank Sector Perform Upgrade
2021-11-12 NationalBankFinancial Outperform Downgrade
2021-09-07 National Bank Financial Outperform Upgrade
2021-05-14 RBC Capital Sector Perform Upgrade
2021-05-14 National Bank Financial Outperform Upgrade
2021-03-15 RBC Capital Sector Perform Upgrade
2019-11-08 RBC Capital Sector Perform Underperform Downgrade
2019-11-05 National Bank Financial Sector Perform Downgrade
2019-08-09 TD Securities Buy Hold Downgrade
2019-08-09 RBC Capital Sector Perform Downgrade
2019-08-09 National Bank Financial Sector Perform Downgrade
2019-03-15 TD Securities Buy Upgrade
2019-03-15 National Bank Financial Sector Perform Downgrade
2019-01-28 National Bank Financial Sector Perform Upgrade
2018-11-09 TD Securities Buy Upgrade
2018-05-11 TD Securities Buy Downgrade
2018-05-11 National Bank Financial Sector Perform Downgrade
2018-05-11 CIBC World Markets Downgrade
2020-12-11 National Bank Financial Outperform Upgrade
2020-11-13 RBC Capital Sector Perform Upgrade
2020-11-13 National Bank Financial Sector Perform Outperform Upgrade
2020-11-03 National Bank Financial Sector Perform Upgrade
2020-08-17 RBC Capital Sector Perform Upgrade
2020-08-17 National Bank Financial Sector Perform Upgrade
2020-04-07 National Bank Financial Sector Perform Downgrade
2020-03-13 RBC Capital Speculative Buy Downgrade
2020-03-05 National Bank Financial Downgrade
2020-02-12 RBC Capital Underperform Sector Perform Upgrade
2019-11-11 National Bank Financial Sector Perform Downgrade
2018-03-25 CIBC World Markets Downgrade
2018-03-19 CIBC World Markets Upgrade
2018-03-15 RBC Capital Sector Perform Upgrade
2018-02-09 TD Securities Buy Downgrade
2018-01-15 Canaccord Genuity Upgrade
2017-11-13 Canaccord Genuity Downgrade
2017-11-10 RBC Capital Sector Perform Downgrade
2017-11-10 National Bank Financial Sector Perform Downgrade
2017-10-31 RBC Capital Sector Perform Downgrade
2017-08-28 Canaccord Genuity Upgrade
2017-08-11 TD Securities Buy Downgrade
2017-08-11 RBC Capital Sector Perform Downgrade
2017-08-11 CIBC World Markets Neutral Downgrade
2017-08-09 National Bank Financial Sector Perform Downgrade
2017-06-14 TD Securities 21 Maintains
2017-06-14 CIBC World Markets Outperform Neutral Downgrade
2017-04-17 TD Securities 23 Maintains
2017-04-06 RBC Capital Outperform Maintains
2017-04-05 CIBC World Markets Outperform Maintains
2016-12-16 RBC Capital Outperform Maintains
2016-10-07 TD Securities Buy Maintains
2016-09-28 Canaccord Genuity Buy Maintains
2016-07-18 Canaccord Genuity Buy Maintains
2016-05-13 Canaccord Genuity Buy Maintains
2015-06-19 RBC Capital Sector Perform Outperform Upgrade
2015-06-08 Canaccord Genuity 17.25 Maintains
2014-03-21 TD Securities Hold Buy Maintains
2014-03-21 RBC Capital Sector Perform Maintains
2014-03-21 National Bank Financial Sector Perform Maintains
2014-03-21 Canaccord Genuity Hold Maintains
2013-11-15 RBC Capital Sector Perform Maintains
2013-11-15 National Bank Financial Sector Perform Maintains
2013-03-22 National Bank Financial 15.5 Maintains
2013-03-22 Canaccord Genuity Hold Maintains
2013-02-13 TD Securities 15 Maintains
2023-03-10 LEEDE JONES GABLE Buy Hold Downgrade
2023-02-01 IA CAPITAL MARKETS Buy Hold Downgrade
2022-09-13 IA CAPITAL MARKETS Hold Buy Upgrade
2022-09-13 LEEDE JONES GABLE Buy Buy Maintains
2022-08-11 IA CAPITAL MARKETS Buy Hold Downgrade
2022-05-06 NATIONAL BANK FINANCIAL Outperform Outperform Maintains
2022-03-10 IA CAPITAL MARKETS Buy Buy Maintains
2023-06-01 LEEDE JONES GABLE Buy Hold Downgrade
2023-01-31 IA CAPITAL MARKETS Buy Hold Downgrade
2022-09-12 LEEDE JONES GABLE Buy Buy Maintains
2022-09-12 IA CAPITAL MARKETS Hold Buy Upgrade
2022-08-10 IA CAPITAL MARKETS Buy Hold Downgrade
2022-05-05 NATIONAL BANK FINANCIAL Outperform Outperform Maintains
2022-03-09 IA CAPITAL MARKETS Buy Buy Maintains
2023-08-10 LEEDE JONES GABLE Hold Hold Maintains
2023-11-10 LEEDE JONES GABLE Hold Hold Maintains
2023-08-11 LEEDE JONES GABLE Hold Hold Maintains
2023-06-02 LEEDE JONES GABLE Buy Hold Downgrade
2024-08-05 LEEDE JONES GABLE Hold Buy Upgrade
2024-03-27 LEEDE JONES GABLE Hold Hold Maintains
2023-11-09 LEEDE JONES GABLE Hold Hold Maintains
2024-11-28 LEEDE JONES GABLE Buy Hold Downgrade
2024-11-06 LEEDE JONES GABLE Buy Buy Maintains
2025-05-07 LEEDE JONES GABLE Hold Hold Maintains
Other Listings
US:MFCSF
DE:31F €9.35
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista